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Langerhans-cell-enriched epidermal cell preparations, 
when pulsed with antigen, can induce proliferative re-
sponses, in immune T cells, that are of the same magni-
tude as those induced by antigen-pulsed macrophages. 
Additionally, these cells bear surface receptors for Fe 
and C3b and display on their cell surfaces determinants 
encoded by genes of the I region of the major histocom-
patibility complex. Histological studies have implicated 
Langerhans cells in cell-mediated immune responses 
such as delayed contact hypersensitivity to 2,4-dinitro-
1-fluorobenzene (DNFB). Langerhans cells play an im-
portant role in the induction of contact sensitivity. When 
murine epidermis that is naturally or artificially de-
pleted of Langerhans cells is painted with DNFB, no 
sensitization occurs. More importantly, animals whose 
initial exposure to DNFB occurs through skin deficient 
in Langerhans cells are unable subsequently to mount 
effective hypersensitivity responses to this agent. We 
therefore believe that Langerhans cells function as pe-
ripheral antigen-presenting cells and that in their ab-
sence the host responds to antigen challenge by becom-
ing specifically unresponsive. 
One of the most intriguing problems in immunology is the 
exploration of the process by which the immune apparatus 
recognizes and responds to antigens. The kind of immune 
response obtained is critically dependent on the route of antigen 
administration. Nowhere is the importance of this factor more 
evident than in models of contact sensitivity. When highly 
reactive substances are applied topically to skin, a strong state 
of specific sensitivity is induced. However, the same compound 
injected intravenously or ingested by mouth produces profound 
specific immunologic unresponsiveness to the eliciting hapten 
[1-4]. Resolution of this paradox requires consideration of the 
mechanism or mechanisms involved in host antigen processing 
when antigen is presented through skin. 
Macher and Chase [5,6], using a ch emical contact sensitivity 
model, have clearly demonstrated an inductive immunologic 
role for skin. They have shown that there is an initial phase 
during which the sensitizing hapten reacts directly with a 
constituent of skin. Although subsequent events in lymph nodes 
are important in processing the signal, interaction between the 
hapten and a skin constituent is required for expression of the 
response. Major histocompatability complex (MHC) products 
and macrophages play a central role in regulation of the immune 
response, especially as regards antigen presentation [7,8]. More 
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importantly, recent studies on contact sensitivity induction 
have also suggested a critical role for macrophages and MHC 
products [9-11]. The elegant transfer experiments of Vadas 
[12,13] have shown that T cells mediating the delayed hyper-
sensitivity response to fowl gamma globulin recognize antigen 
in association with [-region determinants. In light of these 
experiments, it seems likely that the constituent responsible for 
the properties of skin observed by Macher and Chase might be 
macrophage-like cells that bear MHC products. 
Epidermal Langer hans cells resemble macrophages in several 
remarkable respects. Langerhans cells have recently been 
shown to be the only cells within the epidermis that bear Fe 
and C3b receptors [14,15]. Human Langerhans cells bear B cell 
alloantigens on their sw-faces [16], and guinea pig [17] and 
mouse [18] Langerhans cells express Class II gene products (la 
antigens). Although controversy exists, several laboratories 
have recently shown that Langerhans cells are the only cells 
within the epidermis that express cell surface determinants 
encoded by the I region of H-2 [18]. In addition to the remark-
able similarities in surface markers between macrophages and 
Langerhans cells, there are also analogous roles for these 2 cells 
in the initiation of immune responses. Shelley and Juhlin [19] 
have demonstrated that contact allergens applied to skin ac-
cumulate preferentially within Langerhans cells. Recent in vitro 
studies have demonstrated that antigen-pulsed, Langerhans-
cell-enriched epidermal cell preparations can induce prolifera-
tive responses, in immune T cells, that are comparable in 
magnitude to those induced by similarly pulsed macrophages 
[20]. Histological studies have also provided support for an 
immunologic role for Langerhans cells. Frequent close apposi-
tion of lymphocytes to Langerhans cells has been observed at 
sites of contact hypersensitivity reactions [21]. Additionally, 
increased numbers of Langerhans cells have been observed in 
dermal lymphatics and in draining lymph nodes at sites sus-
taining contact hypersensitivity [22]. These observations have 
led to the proposal that Langerhans cells pick up antigen in 
skin and from there move to the draining lymph node, where 
they "present" the antigen to immunologically relevant cells 
[23]. 
We have tested the hypothesis that Langerhans cells are 
critically important in the initiation of contact sensitivity by 
analyzing the degree of sensitivity that results from immuniza-
tion through skin deficient in these cells. We have utilized 2 
observations to study this question: (a) tail skin of mice, unlike 
normal body wall skin, is naturally deficient in Langerhans cells 
[24,25] and (b) ultraviolet light (UVL) treatment of skin tran-
siently depletes it of Langerhans cells [26]. 
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MATERIALS AND METHODS 
Animals 
C57BL/6 mice from The Jackson Laboratory, Bar Harbor, Maine, 
were bred and maintained in our colony. The 2- to 4-mo-old mice were 
age-matched for each experiment and received pelleted food and water 
ad libitum. 
Antigens 
2,4-Dinitro-1-fluorobenzene (DNFB) and 4-ethoxynethylene-2-phen-
lyloxazol-5-one (Oxazalone) were obtained from Sigma Chemical Com-
pany, Saint Louis, Missouri. 
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Sensitization and Elicitation of Contact Sensitivity 
Sites through which mice were sensitized were norma l abdominal 
and dorsal body wall skin; UVL-treated a bdominal waU skin; and tail 
skin. Mice were sensitized to DNFB, i.e., 251-'l of0.5% DNFB in acetone-
olive oil (4:1) were placed on the shaved abdominal skin of recipients 
on day 0 and day 1. Sensitization with Oxazalone was accomplished 
through placement of 25 1-'l of 10% Oxazalone in the above vehicle on 
the abdomen on day 0 and day l. For elicitation of contact sensitivity, 
the ear swelling assay employing painting with the appropriate a ntigen 
on day 5 was used. Ear thickness was quantified with a Mitatoya 
engineer's micrometer as described by Phanupha k et al [3]. The dorsal 
surfaces of the ears were then chaLlenged with either 20 1-'l of 0.2% 
DNFB in acetone-olive oil (4:1) or 20 1-'l of 1% Oxazalone in the same 
vehicle. Later, i.e., 24 and 48 hr after antigen challenge, the degree of 
ear thickness was again measured, and results were expressed in units 
of 10- 4 inches. 
Positive controls consisted of normal mice sensitized on body wall 
skin in the manner described. Negative controls consisted of unsensi-
tized mice whose ears were challenged with the appropriate antigen. 
Each panel (experimental, positive control, and negative control) 
consisted of at least 5 age- and sex-matched animals. (Only 24-hr 
readings were presented in the figUJ·es.) 
Statistical Analysis 
The statistical significance of differences in the means for each 
experimental group was calculated with Student's t-test. Mean differ-
ences were considered significant when p < 0.05. 
Ultraviolet Light: Source and Treatment 
Ultraviolet light was administered with a bank of 3 FS-20 "sun lamp" 
fluorescent tubes (Westinghouse, Pittsbw-gh, Pennsylvania). These 
tubes provided a continuous UV spectrum with a peak at 313 nm and 
high · output in the sunburn spectrum (290 to 320 nm). The tube-to-
target distance was 45 em. The minimal erythemal dose on untanned, 
human skin was 4.0 min, i.e., an output within the erythema range of 
8 X 102 mJ/cm2 sec. 
Langerhans cells were depleted with UVL directed at a 2.5 em by 2.5 
em area of previously shaved abdominal skin on each mouse. This site 
was exposed for 2 min on each of 4 successive days (days -3, -2, -1, and 
0). This dose represented 0.5 minimal erythemal dose in unta nned 
human skin, or 10 mJ/cm2 each day. 
RESULTS 
Is Langerhans Cell Density a Critical Factor in 
Sensitization to DNFB? 
We and others [24] have shown normal murine tail skin to 
have far fewer Langerhans cells than normal abdominal body 
wall skin. Additionally, the Langerhans cell distribution in tail 
skin is nonhomogeneous and forms a gridlike network with very 
low numbers of Langerhans cells in the scales themselves and 
higher numbers in the regions between scales. 
Utilizing this naturally occurring aberration, we investigated 
the relative capacities of tail skin and body wall skin to support 
induction of contact sensitivity. Tail skin did not promote 
sensitization when DNFB was applied, but abdominal wall 
application led to sensitivity (Fig 1) . 
Similar studies were conducted in skin depleted of Langer-
hans cells with UVL. In experiments conducted in our labora-
tory treatment of mouse skin with UVL (4 treatments for 2 min 
at daily intervals for 4 days) resulted in the virtual disappear-
ance of ATPase-positive cells in the epidermis [26]. The abdom-
inal skin of panels of mice were shaved and treated with either 
UVL or incandescent light. After the 4th treatment, mice were 
painted with DNFB as described. The UVL-treated skin, like 
the tail skin, did not promote sensitization when DNFB was 
applied in an immunogenic manner (Fig 2). Incandescent ligh t 
treatment had no discernable effect on sensitization since ap-
plication of DNFB to that skin resulted in strong sensitization. 
These data suggest that a critical concentration of Langerhans 
cells in the skin may be necessa1·y for optimal induction of 
contact sensitivity to DNFB. 
The circumstantial link between surface density of Langer-
hans cells and the ability of skin to permit sensitization was 
strengthened further by studies performed dW"ing a 15-day 
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FIG 1. Role of Langer hans cell density in sensitization to 2,4-dinitro-
1-tluorobenzene (DNFB). Mouse skin was painted with 25 ,ul of 0.5% 
DNFB in carrier on various cutaneous sites on day 0 and day 1. The 
eaT challenge was performed on day 5, and ear swelling was read on 
day 6. Negative controls were not painted, but their ears were chal-
lenged. Bars represent mean swelling for groups of 5 mice ± 1 SEM. 
Abdominal Body Wall 
~~---~~~--------------~ 
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FIG 2. Effect of ultraviolet light (UVL) skin irradiation on sensit i-
zation to 2 ,4-din~tro-1-fluorobenzene (DNFB). Shaved abdominal wa ll 
skin was exposed to UVL oJ· incandescent light (positive control) for 2 
min for 4 days. Skin was painted with DNFB, and ears were cha llenged 
5 days later. Negative controls received ear challenge only. Bars 
represent mean ear swelling for groups of 5 mice ± 1 SEM. 
recovery period after UVL treatment. Skin treated with UVL 
was painted with DNFB at periodic intervals during the recov-
ery period to determine if sensitization could be achieved. The 
capacity to induce contact sensitivity was lost if the epidermis 
was depleted of Langer hans cells, and the capacity returned as 
Langerhans cell density and structure returned to normal (Fig 
3). Thus, the capacity of mice to sustain induction of sensitivity 
to DNFB was cleru·ly impaired if the antigen was presented 
through skin that was either naturally deficient or artificially 
depleted of Langerhans cells. 
Is Exposure of the Epidermis to DNFB in the Absence of 
Langerhans Cells a Null Event? 
Having observed that skin defi cient in Langerhans cells did 
not provide an adequate inductive environment for develop-
ment of contact sensitivity to DNFB, we investigated whether 
this intervention was perceived immunologically as a null event. 
An alternative hypothesis seemed tenable, namely, that DNFB 
exposure tru·ough skin deficient in Langerhans cells altered the 
kind of immune response obtained. We postulated that expo-
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FIG 3. Recovery of contact sensitivity induction after ultraviolet 
light (UVL) skin irradiation. Panels of mice were treated wi th UVL for 
4 days (see Fig 2). Langerhans cell density was determined on days -4, 
0, 6, and 15. Panels of mice were painted with 2,4-dini tro-1-fiuoroben-
zene on days -4, 0, 6, and 15, and their ears were challenged 5 days after 
sensitization. Bars represent mean eaT swelling for groups of 5 mice ± 
1 SEM. 
sure to DNFB in the absence of Langerhans cells allowed 
systemic dissemination of antigen that, like intravenous admin-
istration of antigen, resulted in a state of immunologic unre-
sponsiveness. To test this possibility, we exposed animals pre-
viously treated with DNFB but "unsensitized" to a 2nd sensi-
tizing application of DNFB on previously untreated dorsal body 
wall skin. Application of DNFB to normal dorsal body wall skin 
resulted in strong sensitization (Table 1) . In contrast, animals 
exposed to DNFB through skin deficient in Langerhans cells 
and subsequently exposed to DNFB through normal dorsal 
body wall skin failed to become sensitized. The degree of 
unresponsiveness achieved was 87.5% for tail skin and 80% for 
UVL-treated skin. If tolerance had in fact been achieved, the 
state of unresponsiveness should have been highly specific. As 
shown in Table II, the unresponsiveness induced was highly 
specific for the hapten used in the initial exposure. 2,4-Dinitro-
1-fluorobenzene-unresponsive animals reacted vigorously to Ox-
azalone. From these experiments, we concluded that the im-
munologic reactivity of these animals was profoundly altered 
by exposure to antigens through skin deficient in Langerhans 
cells. These mice responded to a 2nd immunization as though 
they had been rendered profoundly tolerant by the initial 
exposure. This perturbation of the immune system was highly 
specific for the antigen in question, and phenotypically resem-
bled the state of unresponsiveness or tolerance achieved by 
intravenous injection of haptens. 
DISCUSSION 
Our results indicate that a certain threshold number of Lan-
gerhans cells is essential for induction of contact hypersensitiv-
ity to chemical allergens. Additionally, we have shown that 
animals exposed to chemical allergens through skin with "sub-
threshold" numbers ofLangerhans cells not only fail to become 
sensitized but also become profoundly unresponsive. These 
observations suggest that Langerhans cells enable skin to per-
mit and promote the development of a cell-mediated immune 
response. 
A considerable amount of circumstantial evidence suggests 
that epithelial surfaces can be considered lymphoid organs in 
which antigen-reactive lymphocytes recognize antigen and react 
to it. Andrew and Andrew [27] were the first to report the 
presence of lymphocytes in the epidermis. Although that study 
is difficult to interpret because lymphocyte markers were not 
then available, other studies produced clear-cut evidence for 
the presence oflymphocytes in skin. The "passenger" leukocyte 
experiments of Steinmuller [28,29] and studies on toxic epider-
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TABLE I. Langerhans cell density of DNFB treated shin determines 
subsequent immune responses 
None 
First skin pain ting 
(day 0) 
DNFB on a bdominal 
body wall skin 
DNFB on tail skin 
DNFB on UVL-treated 
body wall skin 
Second skin painting 
(day 14) 
DNFB on dorsal body 
wall skin 
DNFB on dorsal body 
wall skin 
DNFB on dorsal body 
wall skin 
DNFB on dorsal body 
wall skin 
Ear swelling 
response x 10- • 
inches± SEM 
50± 1.8 
60 ± 2.0 
15 ± 0.6 
18 ± 0.7 
Abbreviations: DNFB, 2,4-dinitro-1-fluorobenzene: UVL, ultraviolet 
light. 
TABLE II. Specificity of unresponsiveness 
First skin painting Second skin Ear cha llenge Ear swelling re-
(day 0) pa inting (day 14) agent sponse x 10- < ± (day 20) SEM 
DNFB on tail skin DNFB on DNFB 15 ± 0.6 
dorsal body 
wall skin 
DNFB on tail skin Oxazalone on Oxazalone 68 ± 3.0 
dorsal body 
wall skin 
DNFB on UVL- DNFB on DNFB 18 ± 0.7 
treated body dorsal body 
wall skin wall skin 
DNFB on UVL- Oxazalone on Oxazalone 65 ± 2.4 
treated body dorsal body 
wall skin wall skin 
Abbreviations: DNFB, 2,4 -dinitro-l-fluorobenzene; UVL, ultraviolet 
light. 
mal necrolysis by Streilein and Billingham [30,31] have shown 
that cells from peripheral blood, probably lymphocytes, are 
normally present in skin by identifying the presence of their 
transplantation antigens; these cells are immunocompetent and 
are capable of mounting an immune response when confronted 
by histoincompatable antigens [32,33]. These studies have 
shown that, in the skin, lymphocytes can proliferate and differ-
entiate into cells that can mediate an immune response. The 
notion that antigen presentation can occur in peripheral non-
lymphoid tissues is not new. This concept was first proposed by 
Medawar [34], who hypothesized that peripheral sensitization 
might be a distinguishing mark of all delayed hypersensitivity 
reactions. The precise manner by which this peripheral sensi-
tization occurs remains unknown. 
Macrophages appear to play a key role in the induction of 
most immune responses [7,8]. Evidence gathered in the past 
few years suggests that a macrophage-like cell is involved in 
antigen recognition, immune stimulation, and regulation of 
immune responses in skin. Thomas and Shevach [7] have shown 
that presentation of simple chemical haptens toT cells requires 
macrophages, a requirement analogous to that of macrophages 
for T cell responses to protein antigens. Most of these studies 
on macrophage function have been carried out in vitro because 
it is difficult to eliminate macrophages in vivo and functional 
blockade is possible for only brief times. It is in this regard that 
we believe our studies on Langerhans cells are of special inter-
est. 
By using both naturally occurring and experimental pertur-
bations of Langer hans cell density, we have been able to assign 
a pivotal role to epidermal Langerhans cells in the in vivo 
induction of contact (delayed) hypersensitivity. When these 
macrophage-like cells are present in the epidermis in normal 
numbers, they appear to function as peripheral cutaneous an-
tigen-presenting sentinels, the most distal component of the 
afferent limb of the immune response. However, when their 
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network of widespread dendritic processes is significantly al-
tered, a surprising immune response occurs. Not only is sensi-
tization not possible, but exposure to antigen now results in 
unresponsiveness, an indication that the function of these cells 
might be to ensure that the antigens binding to them are 
perceived as immunogens and not tolerogens. 
Several tissues with extensive epithelial surfaces that con-
front the environment have been shown to be associated with 
the immune system in a special way. The aggregate lymphoid 
tissues beneath the epithelium of the gut (including tonsils, 
Peyer's patches, and appendix) are a functional unit, i.e., gut-
associated lymphoid tissue (GALT [35]) . Many laboratories 
have now documented that this unit, although integrated into 
the total immunologic apparatus, also exists as a unique and 
free-standing entity. Its functional integrity is derived from 
recirculating lymphocytes whose migratory pathways constel-
late between GALT and the systemic circulation. The antigenic 
experiences of the lymphocytes and macro phages of GALT are 
not always shared with the rest of the immune system; the 
effector modalities used by this system are similarly specialized. 
For example, GALT is particularly designed to secrete lgA 
antibodies into the gut lumen. The capacity of lymphocytes, 
"schooled" in GALT, to recirculate continually among the gut-
associated lymphoid masses implies the use of a "recognition" 
mechanism that forces these cells to home correctly; we imagine 
that this recognition mechanism, operating independently from 
antigen, links the wandering lymphocytes to gut epithelium. A 
similar unit linked to the pulmonary system has also been 
identified under the acronym BAL T, for bronchus-associated 
lymphoid tissue [36,37]. 
Streilein [38] has proposed that an analogous axis comprising 
recirculating lymphocytes, resident macrophages, and an in-
ductive microenvironment, exists for skin; he has offered the 
term SALT for the putative skin-associated tissue. A great deal 
of circumstantial evidence supports this idea, especially that 
derived from the peculiar proclivity of malignant human T 
lymphocytes to infiltrate the epidermis. In order for the SALT 
analogy to be viable, it is essential that an inductive microen-
vironment for processing and recognizing antigen be identified 
within skin. It is in this context that our studies on epidermal 
Langerhans cells have particular meaning. We have produced 
strong evidence implicating Langerhans cells in the inductive 
immune episode after cutaneous application of antigen. Pro-
cessing and presentation of haptenic antigens via skin contain-
ing threshold or greater numbers of Langerhans cells impart a 
strong immunogenic signal to in1munocompetent lymphocytes. 
We cannot tell from our data, however, whether this signal is 
received by lymphocytes within skin itself, or within the cll·ain-
ing lymph node. Provisionally, we favor the former possibility 
(Fig 4) since we presume that lymphocytes thus activated must 
learn something about skin that destines their future recircu-
lation path between skin and the systemic circulation. The 
epidermis would seem the ideal site for "schooling". In support 
of this notion, Macher and Chase [6] reported that peripheral 
sensitization of lymphocytes to simple chemicals must occur 
before they reach the draining lymph nodes. . 
If Langerhans cells convert potentially tolerogenic signals 
into immunogenic signals, epidermis deficient in these cells 
might be immunologically vulnerable. We have shown that 
corneal epidermis is completely devoid of Langerhans cells [24] 
and that this tissue does not express !-region antigens [39]. 
Viral particles have been reported to be associated with Lan-
gerhans cells [ 40], and cutaneous viral processing may involve 
these cells. The indolent infection of corneal epithelium caused 
by herpes simplex may be related to the absence of these cells. 
Additionally, Langerhans cells may play a pivotal role in in1-
mune surveillance against skin malignancy. Although studies 
on factors that affect the function of these cells or disturb their 
numbers or distribution are limited, UVL clearly alters their 
function. If Langer hans cells prevent development of tolerance, 
an alteration in their function might explain the association 
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epidermis 
heart 
FIG 4. Schematic representation of a hypothesis of skin-associated 
lymphoid tissue· (SALT) . LC, Langerhans cell ; DC, dendritic cell ; T, T 
lymphocyte. 
between sun exposure and skin cancer [41-43]. Neoantigens on 
the membranes of malignant cells arising in UVL-treated skin 
might be perceived as tolerogens rather than antigens because 
of abnormalities in Langer hans cell number or function. Rather 
than being destroyed by the immune system (as would be 
expected if the "non self" antigens were effectively presented 
immunologically) , these cells would be ignored and perhaps 
protected, i.e., allowed to persist and eventually develop into a 
malignancy. 
We wish to thank Mr. Kevin Stasney, Ms. Sabra Sullivan, and Ms. 
Debbie Bate for their exper t technical assistance. The manuscript was 
carefully prepared by Ms. Sara Howard. 
REFERENCES 
1. Chase MW: Hypersensitivi ty to simple chemicals. Harvey Lect 61: 
169-203, 1967 
2. De Week AL, Frey JR: Immunotolerance to simple chemicals. 
Monogr Allergy 1:1-142, 1966 
3. Phanuphak P, Moorhead JW, Claman HN: Tolerance and contact 
sensitivity -to DNFB in mice. I. In vivo detection by ear swelling 
and correlation with in vitro cell stimulation. J Immunol 112: 
115-123, 1974 
4. Claman HN: Tolerance and contact sensitivi ty to DNFB in Mice. 
V. Induction of tolerance with DNP compounds and with free 
and membrane associated DNFB. J Immunolll6:704-709, 1976 
5. Macher E , Chase MW: Studies on the sensitization of animals with 
simple chemical compounds. XI. The fate .o~ la~eled picryl chlo-
nde and dimtrochlorobenzene after sens1tizmg mJections. J Exp 
Med 129:81-102, 1969 
6. Macher E, Chase MW: Studies on the sensitization of animals with 
simple chemical compounds. XII. The influence of excision of 
allergenic depots on onset of delayed hypersensitivity and toler-
ance. J Exp Med 129:103-121, 1969 
7. Thomas DW, Shevach EM: Nature of the antigenic complex rec-
ognized by T lymphocytes. VII. Evidence for a n association 
between TNP-conjugated macrophage membrane components 
and Ia antigens. J Immunoll21:1152-1156, 1978 
8. Rosenthal AS, Shevach EM: Function of macrophages in antigen 
recognition by guinea pig T lymphocytes. I. Requirement for 
histocompat ible macrophage and lymphocytes. J Exp Med 138: 
1194-1212, 1973 
9. Greene MI, Sugimuto M, Benacerraf B: Mechanisms of regulation 
of cell mediated immune responses. I. Effect of route of immu-
nization with TNP coupled syngeneic cells on the induction and 
suppression of contact sensitivity to picryl chloride. J Immunol 
120:1604-1611, 1978 
10. Thomas DW, Forni G, Shevach EM, Greene I: The role of the 
macrophage as the stimulator cell in contact sensitivity. J Im-
munolll8:1677-1681, 1977 
82 TOEWS, BERGSTRESSER, & STREILEIN 
11. Miller SD, Sy M-S, Claman HN: Genetic restrictions for the induc-
tion of suppressor T cells by ha pten-modified lymphoid cells in 
tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity. Role 
of t he H-2D region of the major histocompatibility complex. J 
Exp Med 147:788-799, 1978 
12. Miller JFAP, Vadas MA, Whitelaw A, Gamble J: H-2 gene complex 
restricts transfer of delayed-typed hypersensitivity in mice. Proc 
Nat! Acad Sci USA 72:5059-5098, 1975 
13. Vadas MA, Miller JFAP, Whitelaw AM, Gamble JR: Regulation 
by the H-2 gene complex of delayed type hypersensitivity. Im-
munogenetics 4:137-153, 1977 
14 . Sting! G, Wolff-Schreiner EC, Pichler WJ , Gschnait F, Knapp W, 
Wolff K: Epidermal Langerhans cells bear Fe and C3 receptors. 
Nature 268:245-246, 1977 
15. Berman B, Gigli I: Complemen t receptors on guinea pig epidermal 
Langerhans cells. Clin Res 27:522A, 1979 (abstract) 
16. Sting! G, Katz SI, Abelson LD, Mann DL: Immunofluorescent 
detection of human B cell alloantigens on S-lg-positive lympho-
cytes and epidermal Langerhans cells. J Immunol 120:661-664, 
1978 
17. Sting! G, Katz SI, Shevach EM, Wolff-Schreiner E, Green I: De-
tection of Ia antigens on Langerhans cells in guinea pig skin. J 
Immunol 120:570-578, 1978 
18. Rowden G, Phillips TM, Delovitch TL: Expression of Ia antigens 
by mmine keratinizing epithelial Langerhans cells. Immunoge-
netics 7:465-478, 1979 
19. Shelley WB, Juhlin L: Selective uptake of contact allergens by the 
Langerhans cell . Arch Dermatol 113:187-192, 1977 
20. Sting! G, Katz SI, Clement L, Green I, Shevach EM: Immunologic 
functions of !a-bearing epidermal Langerhans cells. J Immunol 
121:2005-2013, 1978 
21. Silberberg I : Apposition of mononuclear cells to Langerhans cells 
in contact allergic reactions. Acta Derm Venereol (Stockh) 53:1-
12, 1973 
22. Silberberg I, Thorbecke GJ, Baer RL, Rosenthal SA, Berezowsky 
V: Antigen-bearing Langerhans cells in skin, dermal lymphatics 
and in lymph nodes. Cell Immunol 25:137-151, 1976 
23. Shelley WB, Juhlin L: Langerhans cells form a reticuloepithelial 
trap for external contact antigens. Nature 261:46-47, 1976 
24. Bergstresser PR, Fletcher C, Streilein JW: Surface densities of 
Langerhans cells in relation to rodent epidermal sites with special 
immunologic properties. J Invest Dermatol, 74:77-80, 1980 
25. Schweizer J, Marks F: A developmental study of the distribution 
and frequency of Langerhans cells in relation to formation of 
patterning in mouse tail epidermis. J Invest Dermatol 69:198-
Vol. 75, No. 1 
204, 1977 
26. Toews GB, Bergstresser PR, Streilein JW: Epidermal Langerhans 
cell density determines whether contact hypersensitivity or un-
responsiveness follows skin painting with DNFB. J Immunol, 
124:445-453, 1980 
27. Andrew W, Andrew NV: Lymphocytes in the normal epidermis of 
the rat and man. Anat Rec 104:217-232, 1949 
28. Steinmuller D: Immunization with skin isografts taken from toler-
ant mice. Science 158:127-129, 1967 
29. Steinmuller D: Allograft immunity produced with skin isografts 
from immunologically tolerant mice. Transplant Proc 1:593-596, 
1969 
30. Streilein JW, Billingham RE: An a nalysis of graft-versus-host dis-
ease in Syrian hamsters. I. The epidermolytic syndrome: Descrip-
tion and studies on its procurement. J Exp Med 1.32:163-180, 
1970 
31. Streilein JW, Billingham RE: An a nalysis of graft-versus-host dis-
ease in Syrian hamsters. II. The epidermolytic syndrome: Studies 
on its pathogenesis. J Exp Med 132:181-197, 1970 
32. Rapaport FT, Converse JM: Observa tions on immunological man-
ifestations of the homograft rejection phenomenon in man: The 
recall flare. Ann NY Acad Sci 64:836-841, 1957 
33. Zakarian D, Billingham RE: Studies on normal and immune lym-
phocyte reactions in guinea pigs with special reference to the 
cellular contribution of the host. J Exp Med 136:1545-1563, 1972 
34. Medawar PB: Introduction. Br Med Bull 21:97-99, 1965 
35. Moore AR, Hall JG: Evidence for a primary association between 
immunoblasts and small gut. Nature 239:161-162, 1972 
36. Bienenstock J, Johnston N, Perey DYE: Bronchial lymphoid tissue. 
I . Morphologic characteristics. Lab Invest 28:686-692, 1973 
37. Bienenstock J, Johnston N, Perey DYE: Bronchial lymphoid tissue. 
II . Functional characterist ics. Lab Invest 28:693-698, 1973 
38. Streilein JW: Lymphocyte traffic, T cell malignancies and the skin. 
J Invest Dermatol 71:167-171, 1978 
39. Streilein JW, Toews G, Bergstresser P: Corneal allografts fail to 
express Ia antigens. Nature, 282:326-327, 1979 
40. Nagao S, Inaga S, Iijima S: Langer hans cells at the sites of vaccinia 
virus inoculation. Arch Dermatol Res 256:23-31, 1976 
41. Blum HF: Carcinogenesis by Ultraviolet Light. Princeton, Prince-
ton University Press, 1959 
42. Scotto J, Kopf A W, Urbach F: Non-melanoma skin cancer among 
Caucasians in four areas of the United States. Cancer 34:1333-
1338, 1974 
43. Epstein JH: Comparison of the carcinogenic a nd cocarcinogenic 
effects of ultraviolet light on hairless mice. JNCI 34:741-745, 1965 
Announcement 
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San Francisco will be held on September 15~17, 1980. For information, contact Extended Programs in 
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